Choice and Duration of Anticoagulation for Venous Thromboembolism
Aroosa Malik, Nghi B. Ha, Geoffrey D. Barnes
Abstract
Venous thromboembolism (VTE) is a prevalent medical condition with high morbidity, mortality, and associated costs. Anticoagulation remains the main treatment for VTE, though the decision on when, how, and for how long to administer anticoagulants is increasingly complex. This review highlights the different phases of VTE management, with special circumstances for consideration such as antiphospholipid syndrome, coronary artery disease, cancer-associated thrombus, COVID-19, and future anticoagulation options. Anticoagulation management will continue to be a complex decision, applying evidence-based medicine to individual patients with the hope of maximizing effectiveness while minimizing risks.
Topics & Concepts
MedicineVenous thromboembolismIntensive care medicineThrombusAntiphospholipid syndromeDiseaseCoronary artery diseaseVenous thromboembolic diseaseThrombosisSurgeryInternal medicineVenous Thromboembolism Diagnosis and ManagementDiagnosis and Treatment of Venous DiseasesBlood Coagulation and Thrombosis Mechanisms